BSX logo

Boston Scientific Corporation (BSX) Cash From Financing

Annual CFF:

$1.81B+$1.81B(+36180.00%)
December 31, 2024

Summary

  • As of today, BSX annual cash from financing is $1.81 billion, with the most recent change of +$1.81 billion (+36180.00%) on December 31, 2024.
  • During the last 3 years, BSX annual cash from financing has risen by +$1.91 billion (+2009.47%).
  • BSX annual cash from financing is now -78.50% below its all-time high of $8.44 billion, reached on December 31, 2006.

Performance

BSX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

Quarterly CFF:

-$340.00M-$573.00M(-245.92%)
June 30, 2025

Summary

  • As of today, BSX quarterly cash from financing is -$340.00 million, with the most recent change of -$573.00 million (-245.92%) on June 30, 2025.
  • Over the past year, BSX quarterly cash from financing has dropped by -$364.00 million (-1516.67%).
  • BSX quarterly cash from financing is now -104.40% below its all-time high of $7.72 billion, reached on June 30, 2006.

Performance

BSX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

TTM CFF:

$114.00M-$364.00M(-76.15%)
June 30, 2025

Summary

  • As of today, BSX TTM cash from financing is $114.00 million, with the most recent change of -$364.00 million (-76.15%) on June 30, 2025.
  • Over the past year, BSX TTM cash from financing has dropped by -$1.51 billion (-92.98%).
  • BSX TTM cash from financing is now -98.65% below its all-time high of $8.44 billion, reached on December 31, 2006.

Performance

BSX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BSX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+10000.0%-1516.7%-93.0%
3Y3 Years+2009.5%+1.2%+132.4%
5Y5 Years-39.0%-130.8%-70.6%

BSX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+431.0%-121.7%at low-93.7%+118.7%
5Y5-Year-39.0%+431.0%-121.7%+58.5%-93.7%+109.8%
All-TimeAll-Time-78.5%+205.0%-104.4%+65.5%-98.7%+105.7%

BSX Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$340.00M(-245.9%)
$114.00M(-76.2%)
Mar 2025
-
$233.00M(+8.9%)
$478.00M(-73.6%)
Dec 2024
$1.81B(>+9900.0%)
$214.00M(+2957.1%)
$1.81B(+12.3%)
Sep 2024
-
$7.00M(-70.8%)
$1.61B(-0.6%)
Jun 2024
-
$24.00M(-98.5%)
$1.62B(-1.2%)
Mar 2024
-
$1.57B(>+9900.0%)
$1.64B(>+9900.0%)
Dec 2023
$5.00M(+100.9%)
$15.00M(-6.3%)
$5.00M(+155.6%)
Sep 2023
-
$16.00M(-62.8%)
-$9.00M(+96.0%)
Jun 2023
-
$43.00M(+162.3%)
-$224.00M(+63.3%)
Mar 2023
-
-$69.00M(-7000.0%)
-$611.00M(-11.5%)
Dec 2022
-$548.00M(-476.8%)
$1.00M(+100.5%)
-$548.00M(+1.6%)
Sep 2022
-
-$199.00M(+42.2%)
-$557.00M(-58.2%)
Jun 2022
-
-$344.00M(-5633.3%)
-$352.00M(-5766.7%)
Mar 2022
-
-$6.00M(+25.0%)
-$6.00M(+93.7%)
Dec 2021
-$95.00M(-132.4%)
-$8.00M(-233.3%)
-$95.00M(+89.5%)
Sep 2021
-
$6.00M(+200.0%)
-$906.00M(+22.0%)
Jun 2021
-
$2.00M(+102.1%)
-$1.16B(-1901.7%)
Mar 2021
-
-$95.00M(+88.4%)
-$58.00M(-119.8%)
Dec 2020
$293.00M(-90.1%)
-$819.00M(-228.9%)
$293.00M(-24.5%)
Sep 2020
-
-$249.00M(-122.5%)
$388.00M(-80.1%)
Jun 2020
-
$1.10B(+331.6%)
$1.95B(+77.0%)
Mar 2020
-
$256.00M(+135.4%)
$1.10B(-62.9%)
Dec 2019
$2.97B(+107.6%)
-$724.00M(-155.1%)
$2.97B(-27.9%)
Sep 2019
-
$1.31B(+413.3%)
$4.12B(+39.3%)
Jun 2019
-
$256.00M(-88.0%)
$2.96B(-13.7%)
Mar 2019
-
$2.13B(+400.5%)
$3.43B(+139.5%)
Dec 2018
$1.43B(+1201.8%)
$425.00M(+181.5%)
$1.43B(+52.5%)
Sep 2018
-
$151.00M(-79.2%)
$939.00M(+44.7%)
Jun 2018
-
$726.00M(+458.5%)
$649.00M(+154.5%)
Mar 2018
-
$130.00M(+291.2%)
$255.00M(+131.8%)
Dec 2017
$110.00M(+153.4%)
-$68.00M(+51.1%)
$110.00M(-46.6%)
Sep 2017
-
-$139.00M(-141.9%)
$206.00M(-45.6%)
Jun 2017
-
$332.00M(+2313.3%)
$379.00M(+322.9%)
Mar 2017
-
-$15.00M(-153.6%)
-$170.00M(+17.5%)
Dec 2016
-$206.00M(-116.1%)
$28.00M(-17.6%)
-$206.00M(+51.5%)
Sep 2016
-
$34.00M(+115.7%)
-$425.00M(-240.7%)
Jun 2016
-
-$217.00M(-325.5%)
$302.00M(-77.9%)
Mar 2016
-
-$51.00M(+73.3%)
$1.36B(+3.3%)
Dec 2015
$1.28B(+950.7%)
-$191.00M(-125.1%)
$1.32B(-11.8%)
Sep 2015
-
$761.00M(-10.0%)
$1.50B(+98.3%)
Jun 2015
-
$846.00M(+1000.0%)
$756.00M(+1000.0%)
Mar 2015
-
-$94.00M(-571.4%)
-$84.00M(+44.0%)
Dec 2014
-$150.00M(+76.0%)
-$14.00M(-177.8%)
-$150.00M(+62.4%)
Sep 2014
-
$18.00M(+200.0%)
-$399.00M(+28.0%)
Jun 2014
-
$6.00M(+103.8%)
-$554.00M(+16.8%)
Mar 2014
-
-$160.00M(+39.2%)
-$666.00M(-11.7%)
Dec 2013
-$624.00M(+18.3%)
-$263.00M(-92.0%)
-$596.00M(-3.7%)
Sep 2013
-
-$137.00M(-29.2%)
-$575.00M(+15.6%)
Jun 2013
-
-$106.00M(-17.8%)
-$681.00M(+3.4%)
Mar 2013
-
-$90.00M(+62.8%)
-$705.00M(+5.2%)
Dec 2012
-$764.00M(+55.8%)
-$242.00M(+0.4%)
-$744.00M(+7.3%)
Sep 2012
-
-$243.00M(-86.9%)
-$803.00M(-8.7%)
Jun 2012
-
-$130.00M(-0.8%)
-$739.00M(+45.6%)
Mar 2012
-
-$129.00M(+57.1%)
-$1.36B(+21.0%)
Dec 2011
-$1.73B(-240.2%)
-$301.00M(-68.2%)
-$1.72B(+14.7%)
Sep 2011
-
-$179.00M(+76.1%)
-$2.02B(-10.6%)
Jun 2011
-
-$750.00M(-52.7%)
-$1.82B(-82.2%)
Mar 2011
-
-$491.00M(+17.8%)
-$1.00B(-101.8%)
Dec 2010
-$508.00M(+38.0%)
-$597.00M(-4364.3%)
-$496.00M(-1807.7%)
Sep 2010
-
$14.00M(-80.8%)
-$26.00M(+89.4%)
Jun 2010
-
$73.00M(+421.4%)
-$246.00M(+22.6%)
Mar 2010
-
$14.00M(+111.0%)
-$318.00M(+61.2%)
Dec 2009
-$820.00M(+39.3%)
-$127.00M(+38.3%)
-$820.00M(-18.8%)
Sep 2009
-
-$206.00M(>-9900.0%)
-$690.00M(+29.4%)
Jun 2009
-
$1.00M(+100.2%)
-$977.00M(+21.1%)
Mar 2009
-
-$488.00M(>-9900.0%)
-$1.24B(+8.2%)
Dec 2008
-$1.35B
$3.00M(+100.6%)
-$1.35B(+4.2%)
DateAnnualQuarterlyTTM
Sep 2008
-
-$493.00M(-88.9%)
-$1.41B(+13.8%)
Jun 2008
-
-$261.00M(+56.4%)
-$1.63B(-24.7%)
Mar 2008
-
-$599.00M(-969.6%)
-$1.31B(-92.6%)
Dec 2007
-$680.00M(-108.1%)
-$56.00M(+92.2%)
-$680.00M(-11.5%)
Sep 2007
-
-$718.00M(-1239.7%)
-$610.00M(-558.6%)
Jun 2007
-
$63.00M(+103.2%)
$133.00M(-98.3%)
Mar 2007
-
$31.00M(+121.4%)
$7.79B(-7.7%)
Dec 2006
$8.44B(+984.6%)
$14.00M(-44.0%)
$8.44B(+6.2%)
Sep 2006
-
$25.00M(-99.7%)
$7.95B(-5.1%)
Jun 2006
-
$7.72B(+1040.8%)
$8.37B(+1082.6%)
Mar 2006
-
$677.00M(+242.2%)
$708.00M(+174.2%)
Dec 2005
-$954.00M(-317.3%)
-$476.00M(-206.0%)
-$954.00M(+5.2%)
Sep 2005
-
$449.00M(+674.1%)
-$1.01B(+32.3%)
Jun 2005
-
$58.00M(+105.9%)
-$1.49B(-149.6%)
Mar 2005
-
-$985.00M(-86.6%)
-$595.00M(-235.5%)
Dec 2004
$439.00M(-9.9%)
-$528.00M(-1660.0%)
$439.00M(-61.3%)
Sep 2004
-
-$30.00M(-103.2%)
$1.13B(-6.4%)
Jun 2004
-
$948.00M(+1834.7%)
$1.21B(+255.1%)
Mar 2004
-
$49.00M(-70.5%)
$341.00M(-30.0%)
Dec 2003
$487.00M(+378.3%)
$166.00M(+245.8%)
$487.00M(+109.9%)
Sep 2003
-
$48.00M(-38.5%)
$232.00M(+95.0%)
Jun 2003
-
$78.00M(-60.0%)
$119.00M(+440.0%)
Mar 2003
-
$195.00M(+319.1%)
-$35.00M(+80.0%)
Dec 2002
-$175.00M(-140.0%)
-$89.00M(-36.9%)
-$175.00M(-230.2%)
Sep 2002
-
-$65.00M(+14.5%)
-$53.00M(-152.5%)
Jun 2002
-
-$76.00M(-238.2%)
$101.00M(-75.0%)
Mar 2002
-
$55.00M(+66.7%)
$404.00M(-7.6%)
Dec 2001
$437.00M(+168.5%)
$33.00M(-62.9%)
$437.00M(+55.0%)
Sep 2001
-
$89.00M(-60.8%)
$282.00M(+1384.2%)
Jun 2001
-
$227.00M(+158.0%)
$19.00M(+104.6%)
Mar 2001
-
$88.00M(+172.1%)
-$409.00M(+35.9%)
Dec 2000
-$638.00M(-7.6%)
-$122.00M(+29.9%)
-$638.00M(+6.7%)
Sep 2000
-
-$174.00M(+13.4%)
-$684.00M(+6.9%)
Jun 2000
-
-$201.00M(-42.6%)
-$735.00M(-19.3%)
Mar 2000
-
-$141.00M(+16.1%)
-$616.00M(-13.2%)
Dec 1999
-$593.00M(-130.5%)
-$168.00M(+25.3%)
-$544.00M(+11.9%)
Sep 1999
-
-$225.00M(-174.4%)
-$617.17M(-136.5%)
Jun 1999
-
-$82.00M(-18.8%)
$1.69B(-6.7%)
Mar 1999
-
-$69.00M(+71.4%)
$1.81B(-8.4%)
Dec 1998
$1.94B(+1099.4%)
-$241.17M(-111.6%)
$1.98B(-13.1%)
Sep 1998
-
$2.08B(+5134.5%)
$2.27B(+816.3%)
Jun 1998
-
$39.78M(-58.9%)
$248.26M(-5.2%)
Mar 1998
-
$96.68M(+71.7%)
$261.78M(+61.6%)
Dec 1997
$162.00M(-18.7%)
$56.30M(+1.4%)
$162.00M(+17.1%)
Sep 1997
-
$55.50M(+4.1%)
$138.40M(+115.6%)
Jun 1997
-
$53.30M(+1819.4%)
$64.20M(-62.7%)
Mar 1997
-
-$3.10M(-109.5%)
$172.30M(-13.5%)
Dec 1996
$199.30M(+1913.1%)
$32.70M(+274.9%)
$199.30M(+4.9%)
Sep 1996
-
-$18.70M(-111.6%)
$190.00M(-1.6%)
Jun 1996
-
$161.40M(+575.3%)
$193.00M(+430.2%)
Mar 1996
-
$23.90M(+2.1%)
$36.40M(+267.7%)
Dec 1995
$9.90M(+98.0%)
$23.40M(+249.0%)
$9.90M(+193.4%)
Sep 1995
-
-$15.70M(-427.1%)
-$10.60M(-207.1%)
Jun 1995
-
$4.80M(+284.6%)
$9.90M(+67.8%)
Mar 1995
-
-$2.60M(-189.7%)
$5.90M(+18.0%)
Dec 1994
$5.00M(+109.8%)
$2.90M(-39.6%)
$5.00M(+256.3%)
Sep 1994
-
$4.80M(+500.0%)
-$3.20M(+87.7%)
Jun 1994
-
$800.00K(+122.9%)
-$26.10M(+51.9%)
Mar 1994
-
-$3.50M(+34.0%)
-$54.30M(-6.5%)
Dec 1993
-$51.00M(-152.1%)
-$5.30M(+70.7%)
-$51.00M(-11.1%)
Sep 1993
-
-$18.10M(+33.9%)
-$45.90M(-63.9%)
Jun 1993
-
-$27.40M(>-9900.0%)
-$28.00M(-126.4%)
Mar 1993
-
-$200.00K(0.0%)
$106.10M(+8.4%)
Dec 1992
$97.90M(+841.7%)
-$200.00K(0.0%)
$97.90M(-0.2%)
Sep 1992
-
-$200.00K(-100.2%)
$98.10M(-0.2%)
Jun 1992
-
$106.70M(+1370.2%)
$98.30M(+1270.2%)
Mar 1992
-
-$8.40M
-$8.40M
Dec 1991
-$13.20M
-
-

FAQ

  • What is Boston Scientific Corporation annual cash from financing?
  • What is the all-time high annual cash from financing for Boston Scientific Corporation?
  • What is Boston Scientific Corporation annual cash from financing year-on-year change?
  • What is Boston Scientific Corporation quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Boston Scientific Corporation?
  • What is Boston Scientific Corporation quarterly cash from financing year-on-year change?
  • What is Boston Scientific Corporation TTM cash from financing?
  • What is the all-time high TTM cash from financing for Boston Scientific Corporation?
  • What is Boston Scientific Corporation TTM cash from financing year-on-year change?

What is Boston Scientific Corporation annual cash from financing?

The current annual cash from financing of BSX is $1.81B

What is the all-time high annual cash from financing for Boston Scientific Corporation?

Boston Scientific Corporation all-time high annual cash from financing is $8.44B

What is Boston Scientific Corporation annual cash from financing year-on-year change?

Over the past year, BSX annual cash from financing has changed by +$1.81B (+36180.00%)

What is Boston Scientific Corporation quarterly cash from financing?

The current quarterly cash from financing of BSX is -$340.00M

What is the all-time high quarterly cash from financing for Boston Scientific Corporation?

Boston Scientific Corporation all-time high quarterly cash from financing is $7.72B

What is Boston Scientific Corporation quarterly cash from financing year-on-year change?

Over the past year, BSX quarterly cash from financing has changed by -$364.00M (-1516.67%)

What is Boston Scientific Corporation TTM cash from financing?

The current TTM cash from financing of BSX is $114.00M

What is the all-time high TTM cash from financing for Boston Scientific Corporation?

Boston Scientific Corporation all-time high TTM cash from financing is $8.44B

What is Boston Scientific Corporation TTM cash from financing year-on-year change?

Over the past year, BSX TTM cash from financing has changed by -$1.51B (-92.98%)
On this page